Medifron DBT Co., Ltd. 065650.KQ Stock
1289 KRW
{{ price }}
-8.581560%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
66.7B KRW
LOW - HIGH [24H]
1281
-
1413 KRW
VOLUME [24H]
528.62K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
Medifron DBT Co., Ltd. Price Chart
Medifron DBT Co., Ltd. 065650.KQ Financial and Trading Overview
| Medifron DBT Co., Ltd. stock price | 1289 KRW |
| Previous Close | 1622 KRW |
| Open | 1622 KRW |
| Bid | 1632 KRW x 0 |
| Ask | 1633 KRW x 0 |
| Day's Range | 1622 - 1695 KRW |
| 52 Week Range | 1035 - 2370 KRW |
| Volume | 394.53K KRW |
| Avg. Volume | 943.79K KRW |
| Market Cap | 48.46B KRW |
| Beta (5Y Monthly) | 1.664362 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
065650.KQ Valuation Measures
| Enterprise Value | 51.87B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.54248 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.651 |
| Enterprise Value/EBITDA | -27.734 |
Trading Information
Medifron DBT Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.664362 |
| 52-Week Change | -9.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2370 KRW |
| 52 Week Low | 1035 KRW |
| 50-Day Moving Average | 1488.12 KRW |
| 200-Day Moving Average | 1468.03 KRW |
065650.KQ Share Statistics
| Avg. Volume (3 month) | 943.79K KRW |
| Avg. Daily Volume (10-Days) | 1.36M KRW |
| Shares Outstanding | 29.44M |
| Float | 26.59M |
| Short Ratio | N/A |
| % Held by Insiders | 17.08% |
| % Held by Institutions | 0.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | September 30, 2013 |
| Next Fiscal Year End | December 31, 2021 |
Profitability
| Profit Margin | -11.20% |
| Operating Margin (ttm) | -6.89% |
| Gross Margin | 13.54% |
| EBITDA Margin | -5.95% |
Management Effectiveness
| Return on Assets (ttm) | -4.057% |
| Return on Equity (ttm) | -15.46% |
Income Statement
| Revenue (ttm) | 31.41B KRW |
| Revenue Per Share (ttm) | 893.49 KRW |
| Quarterly Revenue Growth (yoy) | 7.90% |
| Gross Profit (ttm) | 4.25B KRW |
| EBITDA | -1870394496 KRW |
| Net Income Avi to Common (ttm) | -3521169152 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.48B KRW |
| Total Cash Per Share (mrq) | 70.63 KRW |
| Total Debt (mrq) | 0 KRW |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.288 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1673940352 KRW |
| Levered Free Cash Flow (ttm) | 10.42B KRW |
Profile of Medifron DBT Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 186, Gasan digital 1-ro |
| ZIP | 08502 |
| Phone | 82 2 545 9277 |
| Website | https://www.medifron.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 33 |
Medifron DBT Co., Ltd., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co., Ltd. was incorporated in 1997 and is based in Seoul, South Korea.
Q&A For Medifron DBT Co., Ltd. Stock
What is a current 065650.KQ stock price?
Medifron DBT Co., Ltd. 065650.KQ stock price today per share is 1289 KRW.
How to purchase Medifron DBT Co., Ltd. stock?
You can buy 065650.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medifron DBT Co., Ltd.?
The stock symbol or ticker of Medifron DBT Co., Ltd. is 065650.KQ.
How many shares does Medifron DBT Co., Ltd. have in circulation?
The max supply of Medifron DBT Co., Ltd. shares is 51.74M.
What is Medifron DBT Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Medifron DBT Co., Ltd. PE Ratio is now.
What was Medifron DBT Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Medifron DBT Co., Ltd. EPS is 0 KRW over the trailing 12 months.